Surgery Partners, Inc. (SGRY)
| Previous close | 35.41 |
| Open | 34.89 |
| Bid | 34.01 x 1100 |
| Ask | 34.12 x 900 |
| Day's range | 33.75 - 35.32 |
| 52-week range | 20.46 - 63.87 |
| Volume | |
| Avg. volume | 908,672 |
| Market cap | 4.184B |
| Beta (5Y monthly) | 2.71 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Surgery Partners, Inc. Reaffirms 2022 Full Year Guidance
BRENTWOOD, Tenn., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 9, 2023, as part of the 41st Annual J.P. Morgan Healthcare Conference, including a presentation at 8:15 p.m. ET. Based on results through November 2022, the Company is re-affirming its 2022 Adjusted EBITDA guidance of $375 million to $385 mil
- GlobeNewswire
Surgery Partners, Inc. To Present At Upcoming Investor Conference
BRENTWOOD, Tenn., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced that Wayne S. DeVeydt, Executive Chairman of the Board, Eric Evans, Chief Executive Officer and Dave Doherty, Chief Financial Officer will meet with investors at the J.P. Morgan Healthcare Conference, including a presentation on Monday, January 9, 2023 at 8:15p.m. (Eastern Time). Interested inves
- GlobeNewswire
Surgery Partners, Inc. Announces Pricing of Upsized $575 Million Public Offering of Common Stock and $225 Million Concurrent Private Placement to Bain Capital
BRENTWOOD, Tenn., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced the pricing of its upsized underwritten public offering of $575 million of its common stock at a public offering price of $24.50 per share. Gross proceeds to Surgery Partners from the offering are expected to be approximately $575 million, before deducting underwriting discounts and commissions and other offering expenses payable by Surgery Partners. In addition, Surgery
